Patients with ulcerative colitis (UC) are looking to avoid recurrent flare-ups of the disease, which can cause significant pain and discomfort. What are some notable factors that have an impact on UC flares that health care professionals can explain to their patients?
One key factor that has developed increasing research interest is the role of a patient’s BMI, specifically those with obesity (BMI > 30 kg/m2), in the development of IBD.
Investigators analyzed the association between consumption of ultra-processed foods and risk for Crohn disease and ulcerative colitis.
Researchers sought to identify disparities in the care and outcomes of patients with IBD of differing races and ethnicities, in order to improve health care equity.
In February 2021, the FDA expanded indications of previously approved medications to include treating ulcerative colitis and neurogenic detrusor overactivity in pediatric patients.
Although the definition of remission varies, the goal of IBD treatment is to achieve and sustain remission.
A team of investigators examined the association between disease activity in individuals with inflammatory bowel disease and the development of symptoms of depression and anxiety.
Investigators analyzed the surgical risk for ulcerative colitis and Crohn disease in contemporary, population-based inception cohorts vs 20th century cohorts.
An analysis of 3 large prospective cohorts examined the association between dietary patterns with high inflammatory potential and increased risks for Crohn disease and ulcerative colitis.
